Schissel DJ, Singer D., David-Bajar K.Azithromycin eruption in infectious mononucleosis: a proposed mechanism of interaction. Cutis. 2000;65:163-166.
3.
Rowley AH, Shulman STKawasaki syndrome. Pediatr Clin North Am. 1999;46:313-329.
4.
Burns JC, Mason WH, Glode MP, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr. 1991;118:680-686.
5.
Tas S., Simonart T.Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Acta Clin Belg. 1999;54:197-200.
6.
Teo L., Tan E.Sulphasalazine-induced DRESS. Singapore Med J. 2006;47:237-239.
7.
Bocquet H., Bagot M., Roujeau JCDrug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15:250-257.
8.
Mainra RR, Card SETrimethoprim-sulfamethoxazoleassociated hepatotoxicity-part of a hypersensitivity syndrome. Can J Clin Pharmacol. 2003;10:175-178.
9.
Morimoto T., Sato T., Matsuoka A., et al. Trimethoprimsulfamethoxazole-induced hypersensitivity syndrome associated with reactivation of human herpesvirus-6. Intern Med. 2006;45:101-105.
10.
Tas S., Simonart T.Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology. 2003;206:353-356.